Evidence map›Paper›PMID 32908754›Full record

ArticleCase reports in otolaryngology2020

Prophylaxis of Upper Airway Infections in a Patient with Partial IgA Deficiency: Concurrent Use of Sublingual Immunotherapy with Inactivated Whole-Cell Bacterial Extract and Der p1.

Paula F Aarestrup, Matheus F Aarestrup, Beatriz J V Aarestrup, Fernando M Aarestrup

Open access · goldAbstract readCase Reports
In one paragraph

Article in Case reports in otolaryngology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact, top 83% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Article
  3. Outer membrane protein C (OMPC) epitope ofFrontiers in immunology · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Paula F AarestrupUniversidade Federal do Rio de Janeiro-UNIRIO, Rio de Janeiro, Brazil.
Matheus F AarestrupInstituto de Ensino Superior Tancredo Neves-IPTAN, São João Del Rei, Minas Gerais, Brazil.
Beatriz J V AarestrupLaboratory of Immunopathology and Experimental Pathology (CBR), Department of Morphology (ICB), Universidade Federal de Juiz de Fora, Juiz de Fora, Minas Gerais, Brazil.
Fernando M AarestrupChairman Laboratory of Immunopathology and Experimental Pathology (CBR), Universidade Federal de Juiz de Fora, Chief Allergy and Immunology Service, Faculdade de Ciências Médicas e da Saúde - SUPREMA e Hospital Maternidade Therezinha de Jesus, Juiz de Fora, Minas Gerais, Brazil.ORCID https://orcid.org/0000-0001-9226-8271
Universidade Federal de Juiz de Fora · BRUniversidade Federal do Rio de Janeiro · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Selective IgA deficiency is the most common type of primary immunodeficiency, but there is not yet a specific effective treatment. The most prevalent clinical manifestations are infectious diseases of the respiratory system. We report herein the case of an 11-year-old female with selective IgA deficiency and recurring episodes of respiratory infections associated with rhinitis and asthma. We evaluated the efficacy of sublingual immunotherapy combined with inactivated whole-cell bacterial extract and Der p1-specific immunotherapy. After 18 months of clinical follow-up, we observed a significant reduction in the number of episodes of respiratory infections associated with control of atopic diseases. We also observed a 3-fold increase in serum IgA levels compared to treatment initiation. This case demonstrates the potential utility of the concurrent use of sublingual immunotherapy with inactivated whole-cell bacterial extract and Der p1 for successful control of allergy and infection in partial selective IgA deficiency.

Identifiers

PMID32908754
PMCPMC7463416
OpenAlexW3080563695

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.